| Literature DB >> 31466331 |
Abstract
People come in contact with a huge number of nanoparticles (NPs) throughout their lives, which can be of both natural and anthropogenic origin and are capable of entering the body through swallowing, skin penetration, or inhalation. In connection with the expanding use of nanomaterials in various industrial processes, the question of whether there is a need to study the potentially adverse effects of NPs on human health becomes increasingly important. Despite the fact that the nature and the extent of damage caused depends on the chemical and the physical characteristics of individual NPs, there are also general mechanisms related to their toxicity. These mechanisms include the ability of NPs to translocate to various organs through endocytosis, as well as their ability to stimulate the production of reactive oxygen species (ROS), leading to oxidative stress, inflammation, genotoxicity, metabolic changes, and potentially carcinogenesis. In this review, we discuss the main characteristics of NPs and the effects they cause at both cellular and tissue levels. We also focus on possible mechanisms that underlie the relationship of NPs with carcinogenesis. We briefly summarize the main concepts related to the role of endogenous mineral organic NPs in the development of various human diseases and their participation in extra-bone calcification. Considering data from both our studies and those published in scientific literature, we propose the revision of some ideas concerning extra-bone calcification, since it may be one of the factors associated with the initiation of the mechanisms of immunological tolerance.Entities:
Keywords: calcium carbonate; carcinogenesis; epithelial-mesenchymal transition; gastric cancer; nanoparticles
Year: 2019 PMID: 31466331 PMCID: PMC6783842 DOI: 10.3390/biomedicines7030065
Source DB: PubMed Journal: Biomedicines ISSN: 2227-9059
Figure 1The main types of anthropogenic and natural nano-objects.
Figure 2The main pro-carcinogenic effects of nano-objects.
The main pro-carcinogenic effects of different types of nano-objects.
| Nano-Objects | Size (nm) | Cell Type/Animal/ | Main Effects | Reference |
|---|---|---|---|---|
|
| ||||
| SWCNT | 228 ± 77 | Pulmonary MDSCs from SWCNT-exposed Wild type mice bearing LLC | Increase in IL-2 production; Suppression of syngeneic T cells proliferation Increase in TGF-β1 production | [ |
| SWCNT | D1–4 x | Murine macrophage cells (RAW 264.7) and murine lung epithelial cells (MLE-15) |
Increasing level of LDH, OPN, and TGF-β; Inhibition of OPN production by anti-OPN antibody reduced the level of TGF-β1 | [ |
| SWCNT | D0.8–0.2 x L100–1000 | Human bronchial epithelial cells (BEAS-2B) |
Induction of malignant transformation in the cells with the initiation of cancer stem-like cells (CSCs); Activation of EMT via the Slug induction; SWCNT-transformed cells exhibited aggressive cancer phenotypes, including increased cell migration and invasion; Subcutaneous injections of SWCNT-transformed cells into nude mice led to the formation of malignant tumors capable of metastasis | [ |
| SWCNTs | D0.8–2.0 | Normal mesothelial cell (NM) and malignant mesothelial cell (MM) cultures |
OH-radical generation and production of ROS; Induction of DNA damage; Activation of PARP, AP-1, NF-kB, p38, and Akt | [ |
| MWCNT | 458 ± 16 | Human macrophages (THP-1), SAE and intestinal (Caco-2/HT29-MTX) cells |
A low level of toxicity for MWCNT; The common response of all three types of cell cultures to TiO2 NPs exposure was the activation of genes transcription responsible for apoptosis, inflammation, antigen presentation, angiogenesis, and epithelial-to mesenchymal transition | [ |
| Graphene quantum dots | N/A | Monocyte-derived DCs, |
Decreased T-cell proliferation and Th1 и Th17 differentiation; Induction of suppressive CD4+CD25+FoxP3+ regulatory T-cells; Decreased production of ROS | [ |
| CNTs, | D1.1 x | Human bronchial epithelial BEAS 2B cells |
Initiation of DNA damage and increased mutation rates in cells | [ |
| CuO | 10 | Undifferentiated and differentiated Caco-2 intestinal cells |
Concentration dependent decrease in cell viability in undifferentiated cells; IL-8 production was over 2-fold higher in undifferentiated cells; Tight junction dysfunction and decreased barrier integrity | [ |
| ZnO | N/A | Chinese hamster lung fibroblast cells (V-79) |
Decrease in cell viability and an increase in ROS; Increase in frequency of HGPRT gene mutation | [ |
| Aminated polystyrene amine, ZnO, Ag | 17 ± 2, 107 ± 45 | HeLa cells |
Induction of cell apoptosis and release of ROS | [ |
| ZnO vs. Ag | 90 | Caco-2 cells |
ZnO NPs exerted higher cytotoxicity than Ag NPs; Significant depletion of superoxide dismutase level and release of ROS | [ |
| ZnO vs. TiO2 | N/A | Caco-2 cells |
Generation of ROS; Increase in IL-8 secretion; DNA damage by ZnO; ZnO NPs was more toxic than TiO2 NPS | [ |
| TiO2 | 30–50 | Human intestinal epithelial cells (IECs) and macrophages |
Release of pro-inflammatory cytokines IL-1β, IL-18; The production of ROS and increasing epithelial permeability in IEC monolayers | [ |
| SiO2 | 15, 55 | Caco-2 cell |
Cell death and chromosome damage; Generation of ROS; Increase in IL-8 secretion; SiO2-15 nm was more toxic than SiO2-55 nm | [ |
| CaCO3 | 40–60 | Mouse embryonic fibroblast NIH 3T3 cell line |
At concentrations of 200 to 400 µg/ml, a slight decrease in cell viability and increase in ROS generation and LDH levels | [ |
| Biomimetic calcium phosphate NPs | <100 | Neutrophils and macrophages isolated from whole blood of volunteers, |
Production of mitochondrial ROS; Activation of caspase-1; Secretion of IL-1β | [ |
| Food nano CaCO3 NPs vs. Food bulk CaCO3 NPs vs. reagent CaCO3 NPs (SS CaCO3) | 100 | Human intestinal epithelial (INT-407) cells |
Food nano CaCO3 exhibited the highest cytotoxicity in terms of ROS generation, membrane damage and LDH release | [ |
| CaCO3 | N/A | Human lung carcinoma A549 cells, |
Small increasing ROS level; Increase in C/EBP-homologous protein (CHOP) expression and the activation of caspase-3 | [ |
| CaCO3 | 35–60 | MC3T3-E1 and hFOB 1.19 osteoblast cell lines |
CaCO3 NPs exhibit a low cytotoxicity and genotoxicity; Increase in TGF-β1, VEGF levels and cell proliferative activity | [ |
| CaCO3/CaP/ | N/A | 293T cells, HeLa cells |
Cellular uptake and nuclear localization of CaCO3/CaP/DNA NPs were significantly enhanced as compared with CaCO3/DNA NPs | [ |
| Protamine sulfate -calcium carbonate-plasmid DNA (PS-CaCO3-DNA) NPs | N/A | 293T cells, |
PS-CaCO3-DNA nanoparticles were more effective in gene delivery than both PS-DNA NPs CaCO3-DNA NPs | [ |
|
| ||||
| MWCNT | D10 x | C57BL/6J mice |
Bronchioloalveolar inflammation; Hyperplasia, hypertrophy and metaplasia of the bronchiolar epithelium, lung fibrosis; Vascular changes by type of vasculitis | [ |
| MWCNT | N/A | C57BL/6 mice |
Pleural granulomas formation; The release of cytokines and oxidants which damage of the mesothelial and endothelial cells, enhance inflammation, fibrosis and genotoxicity; Pro-inflammatory and pro-carcinogens effects of MWCNT were observed only when the nanotubes were long and thin | [ |
| SWCNT | D100 x | C57BL/6 mice |
Increasing level of LDH, TGF-β1, TNF-α and IL-6 in BAL; Increase in concentration of lipid peroxidation products in lung homogenates; Significant depletion of total antioxidant status in lung homogenates; SWCNT inhalation is more toxic than aspiration | [ |
| CNF vs. | D80–60 x L5000–30,000 | C57BL/6 mice |
Induction of chronic bronchopneumonia, pulmonary fibrosis and lymphadenitis; Genotoxic effects and increase in the incidence of Inflammation was more severe in asbestos- and CNF-treated mice whereas the severity of fibrotic and genotoxic effects - in SWCNT-treated mice | [ |
| Porous silicon NPs | 200 | C57BL/6 mice, |
Increase by 5-fold in the number of splenic CD4+CD25+FoxP3+ regulatory T-cells compared to control mice | [ |
| PLG(Ag) | 450–850 | Mouse model (SJL/J mice) of EAE |
Complete prevention of EAE after intravenous administration of PLG+PLP; Significant increase in PD-L1 expression in Kupffer cells, macrophages and dendritic cells of hepar | [ |
| Ag, Au, Fe3O4, SiO2, ZnO, CuO, NiO, MnO, PbO, Al2O3, TiO2 | 3.4–1000 | Outbred white rats |
Ultrastructural abnormalities in cells of the liver, spleen, kidney, myocardium, brain, thymus, and testicle tissues did not depend on the NPs type; Cytotoxicity manifested by vacuolization of the cytoplasm, damage of mitochondria with partial or complete loss of cristae; Genotoxic effect | [ |
| TiO2 | 30–50 | C57BL/6J and NLRP3-deficient mice |
A more severe colitis with a significant shortening of the colon; A higher inflammatory cell infiltration with a severe disruption of the mucosal epithelium in TiO2-treated mice | [ |
| TiO2 | 66, 260 | Bl 57/6 male mice |
Increase in the levels of IL-12, IL-4, IL-23, TNF-α, IFN-γ, and TGF-β in samples of jejunum and ileum; Increase in the levels of T CD4+ cells in duodenum, jejunum, and ileum | [ |
| TiO2 | 300 | BALB/c male |
Dysplastic alterations in the distal colon; Increase in the levels of tumor progression markers in the small intestine | [ |
| TiO2 (E-171) | 80–100 | Wistar rats |
Increase in the number of preneoplastic lesions in colon; Significant increases in TNF-α, IL-8, and IL-10 levels in the colonic mucosa of E171-treated rats without activation of caspase-1 | [ |
| TiO2 | 33, 160 | CBAB6F1 mice |
Induction of DNA-damage in the cells of bone marrow and liver; Increase in the mitotic index in forestomach and colon epithelia, and apoptosis in forestomach and testis | [ |
| TiO2 | 14–50 | Balb/c mice to |
Increase in ROS generation, levels of immunoglobulin E, IL-8, 8-hydroxy-2′-deoxyguanosine, soluble intercellular adhesion molecule-1, and C-reactive protein. | [ |
| Ag | 60 | Sprague-Dawley rats |
Initiation of a non-specific colitis which increased secretion of mucus in the ileum and rectum | [ |
| Ag-polymer conjugate NPs | 80, 400 | SJL/J mice, |
Increase in generation of CD4+CD25+FoxP3+ regulatory T-cells by BMDCs that were generated from the bone marrow of C57BL/6J mice treated with NPs | [ |
| CaCO3 | 30 ± 5 | Sprague-Dawley rats |
Anorexic, dyspnoeic, fever, tachycardia and a serious gangrene lesion; Increased in levels of ALT, ALP, AST, bilirubin, urea, and creatinine; Granular lesions in the liver, congestion of the heart and the kidneys; Multifocal interstitial polymorphonuclear infiltration and vacuolar degenerations and necrosis of renal tubules in kidneys; Generalized congestion and had exudates in the lungs | [ |
|
| ||||
| MWCNT | D30–80 x L500–5000 | B6C3F1 mice |
Lung cancer or bronchiolo-alveolar adenoma were in 11% of mice - in air group, in 18% - in MWCNT, in 33% - in MCA and in 76% - in MCA + MWCNT group; Five mice (9%) exposed to MCA and MWCNT and 1 (1.6%) exposed to MCA also developed tumors morphologically corresponding to sarcomatous mesotheliomas | [ |
| MWCNT-7 | D30–80 x | F344 rats and B6C3F1 mice |
Results are presented for maximum NPs concentrations
Pleural mesothelioma - in 15.8% rats, lung carcinoma – in 36.8%, 0% - in control group Lung carcinoma in 22% mice in MCA group, in 62% in MCA+MWNT-7 Peritoneal mesothelioma in 87.5% in mice, in 87,5% in rats, 0% in control group No tumor induction | [ |
| MWCNTs | D40–90 x | F344 rats |
22% and 16% cases of lung cancer in males and females. Lung carcinomas were mainly bronchiolo-alveolar carcinomas | [ |
| SWCNT | 230 | C57BL/6 mice and TGF-β-deficient mice |
Increase in the number and size of tumor nodules in the lung; Increase in numbers of MDSC in lymphoid tissues, lung, spleen and bone | [ |
| Calcium oxalate | N/A | BALB/c or BALB/c nude mice |
All mice had breast cancer on day 20 of experiment | [ |
| CaCO3 | 7.8 ± 10.8, | Wistar rats |
Gastric intraepithelial carcinomas with extensive invasion of individual tumor cells and their clustering into the muscle layer and serosa, as well as into the omentum and blood vessels (100% rats) | [ |
Abbreviations: D—diameter; L—length; Akt—protein kinase B alpha; ALP—alkaline phosphatase; ALT—alanine transaminase; AP-1—activator protein 1; AST—aspartate transaminase; BAL—bronchoalveolar lavage; BMDCs—bone-marrow-derived dendritic cells; CAC—colitis associated cancer; C/EBP—CCAAT/enhancer binding protein; CNTs—carbon nanotubes; CSCs—cancer stem-like cells; DCs—dendritic cells; DNA—deoxyribonucleic acid; Dox—doxorubicin; DSS—dextran sodium sulfate; EAE—autoimmune encephalomyelitis; EMT—epithelial-mesenchymal transition; GNFs—graphite nanofibers; nHAPs—nanohydroxyapatites; HGPRT—hypoxanthine-guanine phosphoribosyl transferase; IECs—intestinal epithelial cells; IFN—interferon; IL—interleukin; LDH—lactate dehydrogenase; LLC—Lewis lung carcinoma; MCA—methylcholanthrene; MDSCs—myeloid-derived suppressor cells; MLE—murine lung epithelial cells; MWCNR—multi-walled carbon nanotubes; NF-κB—nuclear factor kappa B; NPs—nanoparticles; OPN—osteopontin; PARP—Poly-(ADP-ribose) polymerases; PLG—Poly(lactide-co-glycolide); PD-L1—ligand 1 of programmed cell death protein; PLP—myelin proteolipid protein; PS-CaCO3-DNA—protamine sulfate -calcium carbonate-plasmid DNA; ROS—reactive oxygen species; SAE—small airway epithelial; SWCNT—singe-walled carbon nanotubes; TNF-α—tumor necrotic factor-α; TGF-β—transforming growth factor beta; VEGF—vascular endothelial growth factor.